By Dirk Brinckman Chief Compliance Officer, Johnson & Johnson Chair, IFPMA Ethics and Business Integrity Committee Chair, ...

IFPMA submitted a statement at the start of the 17th meeting of the Conference of the Parties to the Convention on Biological ...

On 13 October 2026, on the occasion of the adoption of the Political Declaration on Pandemic Prevention, Preparedness, and ...

This infographic shows how just a 1% increase in seasonal influenza vaccination coverage can deliver substantial health and economic benefits. It highlights influenza’s global disease burden, ...

Governments around the world are confronting increasingly common challenges: how to drive economic growth, address demographic changes and productivity pressures, and how to strengthen national ...

This event has now passed. To browse our upcoming events click here. Scientific progress can only realize its full potential when accompanied by public confidence in the institutions, expertise and ...

The innovative biopharmaceutical industry, having developed COVID-19 vaccines and treatments at record speed and in historic quantities, proposes to create a collaborative solution for more equitable ...

17 October 2023, Geneva – A draft of the World Health Organization (WHO) Intergovernmental Negotiating Body’s (INB) international instrument on pandemic prevention, preparedness and response, commonly ...

The 77th World Health Assembly (WHA) marks the deadline for the conclusion of a pandemic agreement and amended International Health Regulations (2005) that seek to make the world better prepared for ...

IFPMA recognizes the work underway at the local and regional level, both within IFPMA member associations and various non-governmental organizations. Thus, the objective of this Note for Guidance is ...